1. Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis
   Mei-Hong Lin et al, 2022, Digestive Diseases and Sciences CrossRef
2. Serum qAnti‐HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg‐positive immune active patients
   Xiaomei Wang et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
3. Baseline albumin-bilirubin score: a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment
   Yao Zhang et al, 2023, European Journal of Gastroenterology & Hepatology CrossRef
4. Hepatitis B infection and intrahepatic cholestasis of pregnancy
   Ruoan Jiang et al, 2020, Medicine CrossRef
5. A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase
   Ling Li et al, 2021, Medicine CrossRef
6. A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
   Lu Zhang et al, 2023, Frontiers in Immunology CrossRef
7. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay
   Yameng Pei et al, 2019, ACS Infectious Diseases CrossRef
8. Comparative metabolomics unveils molecular changes and metabolic networks of syringin against hepatitis B mice by untargeted mass spectrometry
   Yi-chang Jiang et al, 2020, RSC Advances CrossRef
9. HbsAg seviyesinin HBV DNA ve karaciğer fibrozisi ile ilişkisi
   Ahmet Ramiz BAYKAN et al, 2023, Akademik Gastroenteroloji Dergisi CrossRef
10. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B
    Jianhua Hu et al, 2019, European Journal of Gastroenterology & Hepatology CrossRef
11. A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis
    Hea‐Jong Chung et al, 2018, FEBS Open Bio CrossRef
12. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
    Da-Wu Zeng et al, 2016, World Journal of Gastroenterology CrossRef
13. Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China
    Wen Jia et al, 2015, Hepatitis Monthly CrossRef
14. Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products
    Wei Liu et al, 2018, Stem Cell Research & Therapy CrossRef
15. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients
    Zhan-qing Zhang et al, 2020, Gastroenterología y Hepatología (English Edition) CrossRef
16. A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
    Ning Wang et al, 2022, Medicina CrossRef
17. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients
    Zhan-qing Zhang et al, 2020, Gastroenterología y Hepatología CrossRef
18. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection
    Da-Wu Zeng et al, 2016, World Journal of Gastroenterology CrossRef
19. Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
    Lu Zhang et al, 2023, Virulence CrossRef
20. Clinical characteristics and association analysis of persistent low‑level HBsAg expression in a physical examination population with HBV infection
    Yuzhu Dai et al, 2019, Experimental and Therapeutic Medicine CrossRef